UONDDL
AXSM icon

University of Notre Dame du Lac’s Axsome Therapeutics AXSM Stock Holding History

University of Notre Dame du Lac’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,137
Closed -$714K – 35
2020
Q1 		$714K Buy
+12,137
New +$989K 0.22% 52

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

University of Notre Dame du Lac's AXSM Position: Q2 2020 in Review

University of Notre Dame du Lac sold out of Axsome Therapeutics (AXSM) in Q2 2020, closing a stake of 12,137 shares — an estimated $714K sold.

University of Notre Dame du Lac first reported a position in AXSM in Q1 2020 and held it in 1 quarter. The position peaked at $714K in Q1 2020. 190 funds tracked by Wall St. Rank hold AXSM as of Q2 2020.

  • University of Notre Dame du Lac reported no remaining Axsome Therapeutics position as of Q2 2020 after selling out during the quarter.
  • University of Notre Dame du Lac sold 12,137 Axsome Therapeutics shares in Q2 2020, an estimated $714K.
  • University of Notre Dame du Lac first reported a position in Axsome Therapeutics in Q1 2020 and held it in 1 quarter.
  • University of Notre Dame du Lac's Axsome Therapeutics position peaked at $714K in Q1 2020.
  • 190 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2020.

Based on University of Notre Dame du Lac's 13F filing for Q2 2020, filed 14 Aug 2020.